- Home
- VIR vs OPK Comparison
VIR vs OPK Comparison
Compare VIR & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- OPK
- Stock Information
- Founded
- VIR 2016
- OPK 2007
- Country
- VIR United States
- OPK United States
- Employees
- VIR N/A
- OPK N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- VIR Health Care
- OPK Health Care
- Exchange
- VIR Nasdaq
- OPK Nasdaq
- Market Cap
- VIR 1.4B
- OPK 1.3B
- IPO Year
- VIR 2019
- OPK 1995
- Fundamental
- Price
- VIR $7.00
- OPK $1.72
- Analyst Decision
- VIR Buy
- OPK Strong Buy
- Analyst Count
- VIR 6
- OPK 3
- Target Price
- VIR $35.67
- OPK $2.75
- AVG Volume (30 Days)
- VIR 1.1M
- OPK 8.3M
- Earning Date
- VIR 05-01-2025
- OPK 05-06-2025
- Dividend Yield
- VIR N/A
- OPK N/A
- EPS Growth
- VIR N/A
- OPK N/A
- EPS
- VIR N/A
- OPK N/A
- Revenue
- VIR $74,205,000.00
- OPK $713,142,000.00
- Revenue This Year
- VIR N/A
- OPK N/A
- Revenue Next Year
- VIR $17.69
- OPK $6.25
- P/E Ratio
- VIR N/A
- OPK N/A
- Revenue Growth
- VIR N/A
- OPK N/A
- 52 Week Low
- VIR $6.56
- OPK $0.86
- 52 Week High
- VIR $14.45
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- VIR 28.28
- OPK 49.72
- Support Level
- VIR $6.96
- OPK $1.85
- Resistance Level
- VIR $7.46
- OPK $1.95
- Average True Range (ATR)
- VIR 0.57
- OPK 0.10
- MACD
- VIR -0.16
- OPK -0.01
- Stochastic Oscillator
- VIR 1.56
- OPK 23.81
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.